✉news HealthMedicine first seen 17 h ago, last 17 h ago, peak #34
The Next Wave of Obesity Medicines Beyond Semaglutide and Tirzepatide
Original: Beyond Semaglutide and Tirzepatide: The Next Wave of Obesity Medicines
A new wave of obesity medicines is being discussed as the field looks beyond the established GLP-1 drugs semaglutide and tirzepatide. Coverage highlights emerging treatments in development that could expand options for patients and clinicians treating obesity, a category that has drawn enormous attention since GLP-1 therapies reshaped weight-loss care. Details on specific drug candidates remain limited.
Why now: Ongoing high interest in obesity treatments as newer weight-loss drugs move through development
Evidence
- Beyond Semaglutide and Tirzepatide: The Next Wave of Obesity Medicines · Patient Care Online
API: https://socialmediatrends-api.osmike.com/v1/trends/451044